🔎 Trials Near Me

Akèy › Hyperinsulinisme

Etid klinik pou Hyperinsulinisme ap rekrite nan Etazini

12 etid pou Hyperinsulinisme ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06881992

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 7 a 70 · Tout sèks · Mizajou Sep 16, 2026 · NCT03374215

Graded Insulin Suppression Test P&F

Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 8, 2026 · NCT06592261

Alpelisib Challenge Test (ACT)

Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Sep 3, 2026 · NCT07778524

Human Models of Selective Insulin Resistance: Alpelisib, Part I

Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Aug 24, 2026 · NCT06354088

Effect of Insulin Lowering on Lipogenesis

Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Jul 6, 2026 · NCT07403604

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy

Ap rekriteFaz 1
Laj 18 ak plis · Fanm · Mizajou May 22, 2026 · NCT05989347

Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou May 1, 2026 · NCT05950282

Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes

Ap rekriteVolontè an sante akeyi
Laj 12 a 17 · Fanm · Mizajou Apr 22, 2026 · NCT05543083

Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 22, 2026 · NCT05455619

Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism

Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Dec 19, 2025 · NCT05088798

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Ap rekriteFaz 1
Jiska laj 18 · Tout sèks · Mizajou Jul 16, 2024 · NCT02021604

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.